The past 5–10 years have brought in a new era in the care of patients with thyroid cancer,
with the introduction of transformative diagnostic and management options. Several …

The state of thyroid cancer in 2021 is reviewed including the prevalence of thyroid cancer,
vulnerable patient groups such as women and young adults, and known and hypothesized …

Thyroid cancers are a diverse group of malignant disorders ranging from indolent
micropapillary carcinoma, which has no effect on life expectancy, to anaplastic tumours …

Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over
62 000 new cases occurred in men and women in 2015. The incidence continues to rise …

In the past 30 years, there has been a substantial rise in the detection of thyroid nodules.
Largely asymptomatic, thyroid nodules are most often incidental findings that typically pose …

This is the official guideline endorsed by the specialty associations involved in the care of
head and neck cancer patients in the UK. This paper provides recommendations on the …

Thyroid carcinomas are fairly uncommon and include disease types that range from indolent
localised papillary carcinomas to the fulminant and lethal anaplastic disease. Several …

Thyroid cancer is an increasingly prevalent malignancy throughout the world. Management
guidelines for both thyroid nodules and thyroid cancer have been published and updated by …

Thyroid nodules are common, usually asymptomatic, and often pose minimal risk to the
affected patient. However, 10–15% prove malignant and serve as the rationale for …

This ESMO Clinical Practice Guideline provides updated state-of-the-art recommendations
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …